The Problem
The financial burden of Chronic Obstructive Pulmonary disease is Too High. Patients have a 30-day readmission rate of 24%.
Our Solution
Our solution is the world's first wearable multimodal physiological sensing system. Our technology addresses the data gap to reduce hospitalization cost and readmission rates.
Technology
Our wearable solution creates a portfolio of physiological parameters that allow for a comprehensive cardiopulmonary assessment to be used for early symptom identification and treatment.
About Us
Lasarrus
Currently, there are over 16.4 million people in the U.S. who suffer from COPD. Of those, 24% of them will be readmitted to the hospitals due to increased symptoms or severity. At LASARRUS we are creating device-enabled solutions for remote monitoring of Chronic Obstructive Pulmonary Disease (COPD) that is reliable, accurate and easy to use.
Our Founders.
LASARRUS is founded by four brothers with over 50 years of cumulative professional experience, with each bringing a unique value to the success of the company.
Our Team.
Our Advisors
AS FEATURED ON
We Take Pride In Being The 2018 Intel Design Contest Winners
Intel FPGA Innovation Day
"A master class in FPGA-inspired technology innovation."
_svg.png){kind=logo}